Cytosorbents Corporation
Cytosorbents Corporation（CTSO）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CTSO · 截至 2026年6月9日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Cytosorbents Corporation内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CTSO 季度内部人买卖趋势
CTSO 内幕交易卖出 · CTSO 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CTSO CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CTSO 高管卖出股份 · CTSO 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Nov 18, 2025 | Chan Phillip P. CEO · Director | Award | 100,000 | $64K | Form 4 |
| Aug 8, 2025 | Chan Phillip P. CEO · Director | Award | 105,600 | — | Form 4 |
| Aug 8, 2025 | MARIANI PETER J CFO | Award | 71,500 | — | Form 4 |
| Aug 8, 2025 | Capponi Vincent President and COO | Award | 89,100 | — | Form 4 |
| Aug 8, 2025 | Deliargyris Efthymios Chief Medical Officer | Award | 70,000 | — | Form 4 |
| Feb 24, 2025 | BATOR MICHAEL G. Director | Other | 10,000 | $11K | Form 4 |
| Feb 24, 2025 | Capponi Vincent President and COO | Other | 12,000 | $14K | Form 4 |
| Feb 24, 2025 | MARIANI PETER J CFO | Other | 32,625 | $37K | Form 4 |
| Feb 24, 2025 | Chan Phillip P. CEO · Director | Other | 34,168 | $39K | Form 4 |
| Feb 24, 2025 | Sobel Alan D. Director | Other | 21,950 | $25K | Form 4 |
| Jan 17, 2025 | BATOR MICHAEL G. Director | Other | 15,879 | $16K | Form 4 |
| Jan 17, 2025 | Capponi Vincent President and COO | Other | 31,760 | $32K | Form 4 |
| Jan 17, 2025 | Deliargyris Efthymios Chief Medical Officer | Other | 16,233 | $16K | Form 4 |
| Jan 17, 2025 | Sobel Alan D. Director | Other | 21,950 | $22K | Form 4 |
| Jan 17, 2025 | Chan Phillip P. CEO · Director | Other | 90,832 | $91K | Form 4 |
| Jan 17, 2025 | MARIANI PETER J CFO | Other | 32,625 | $33K | Form 4 |
| Dec 13, 2024 | MARIANI PETER J CFO | Purchase | 20,000 | $19K | Form 4 |
| Dec 12, 2024 | MARIANI PETER J CFO | Purchase | 20,000 | $18K | Form 4 |
| Dec 11, 2024 | MARIANI PETER J CFO | Purchase | 11,363 | $10K | Form 4 |
| Aug 14, 2024 | MARIANI PETER J CFO | Award | 175,000 | — | Form 4 |
| Aug 14, 2024 | MARIANI PETER J CFO | Award | 65,000 | — | Form 4 |
| Aug 14, 2024 | MARIANI PETER J CFO | Award | 110,000 | — | Form 4 |
| Apr 2, 2024 | Deliargyris Efthymios Chief Medical Officer | Award | 61,000 | — | Form 4 |
| Apr 2, 2024 | BLOCH KATHLEEN P. CFO | Award | 65,000 | — | Form 4 |
| Apr 2, 2024 | Capponi Vincent President and COO | Award | 81,000 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CTSO 内幕交易
CTSO 内幕交易
Cytosorbents Corporation（CTSO）内幕交易数据来源于公司内部人（包括Chan Phillip P. (CEO · Director), MARIANI PETER J (CFO), Capponi Vincent (President and COO)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。CTSO内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cytosorbents Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CTSO 内幕交易 · 5个问题Cytosorbents Corporation（CTSO）的内部人包括高管和董事，如Chan Phillip P. (CEO · Director), MARIANI PETER J (CFO), Capponi Vincent (President and COO)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026